Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Pulmonary Nodule 1Smoking Cessation 1Ovarian Neoplasms 1Multiple Pulmonary Nodules 1Mesothelioma 1Lymphoma, B-Cell 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Cigarette Smoking 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Oxygen 2Anterior Temporal Lobectomy 2Tomography, X-Ray Computed 1Thoracoscopy 1Technetium Tc 99m Aggregated Albumin 1Nitrous Oxide 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Indocyanine Green 1Hematologic Tests 1Fluorodeoxyglucose F18 1Carbon Dioxide 1Blood Specimen Collection 1Anti-Bacterial Agents 14-fluoroglutamine 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Solitary Pulmonary Nodule × 4-(3-fluoropropyl)glutamic acid × Clear all
NCT02448225 2022-10-19

18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
46 enrolled 12 charts
Thoracic

Cigarette Smoking, Solitary Pulmonary Nodule, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡